Synapse - Angela Green

Results (40)

Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: A comprehensive molecular and pathologic analysis

Journal Article

Lam, C.; Zhou, Q.; Aghajanian, C.; Abu-Rustum, N. R.; Mueller, J. J.; Ellenson, L. H.; Green, A. K.; Weigelt, B.; Jungbluth, A. A.; Momeni-Boroujeni, A.
Gynecologic Oncology (2025)

Fulltext@MSK | Save

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Journal Article

Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
Gynecologic Oncology (2025)

Fulltext@MSK | Save

Quality of treatment selection for medicare beneficiaries with cancer

Journal Article

Mitchell, A. P.; Persaud, S.; Mishra Meza, A.; Fuchs, H. E.; De, P.; Tabatabai, S.; Chakraborty, N.; Dey, P.; Trivedi, N. U.; Mailankody, S.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment

Journal Article

Mao, J. J.; Bryl, K.; Gillespie, E. F.; Green, A.; Hung, T. K. W.; Baser, R.; Panageas, K.; Postow, M. A.; Daly, B.
npj Digital Medicine (2025)

Fulltext@MSK | Save

A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer

Meeting Abstract

Dockery, L.; Musa, F.; Mathews, C.; Spirtos, N.; Slomovitz, B.; Priebe, A.; Green, A.; Puechl, A.; Birrer, M.; Herzog, T.; more...
International Journal of Gynecological Cancer (2024)

Fulltext@MSK | Save

Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer

Meeting Abstract

Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
International Journal of Gynecological Cancer (2024)

Fulltext@MSK | Save

nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study

Meeting Abstract

Dockery, L.; Slomovitz, B.; Priebe, A.; Green, A.; Mathews, C.; Musa, F.; Puechl, A.; Birrer, M.; Spirtos, N.; Ding, L.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Analysis of inactivating TSC1 and TSC2 alterations in a real-world patient population with advanced gynecologic cancers in the Foundation Medicine genomic database

Meeting Abstract

Dockery, L.; Richardson, D.; Neff, R.; Green, A.; Priebe, A.; Iyer, G.; Palma, N.; Navarro, W.; Moore, K.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer